Mark Sabag

See "Remarks" · Teva Pharmaceutical Industries

Mark Sabag (See "Remarks") filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $6.2M of TEVA (216,892 sh across 2 lots, as filed), executed Dec 9 2025. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.1M

shares × price, as filed

Last traded

Nov 5

Filed Nov 6

Median ADV $196.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $24.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

TEVA

Teva Pharmaceutical Industries Limited TEVA · 0 buys · 6 sells 6 filings

Recent filings

TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.9M
46,000 sh × $41.93
Exec Nov 5
Filed Nov 6 · 4:03 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $5.0M
144,180 sh × $34.99
Exec May 1
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.9M
62,102 sh × $30.14
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $6.2M
216,892 sh across 2 lots
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $6.1M
337,915 sh × $18.04
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $2.9M
177,626 sh × $16.25
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET